We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current LIANY market cap is 32.28M. The company's latest EPS is USD and P/E is N/A.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -24.34M | -134.87M | -195.57M | -125.35M | -99.63M |
| Net Income | -24.33M | -139.6M | -196.3M | -110.29M | 311.41M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 43.88M | 279.29M | 426.34M | 319.96M | 617.96M |
| Total Liabilities | 3.7M | 27.57M | 39.01M | 26.31M | 36.77M |
| Total Equity | -14.82M | -98.07M | 387.34M | 293.65M | 581.2M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -11.7M | -98.14M | -163.95M | -99.19M | 259.16M |
| Investing | N/A | -886k | -155.94M | -69.2M | 99.4M |
| Financing | 55M | 309.75M | 313.27M | 1.71M | 1.78M |
| Market Cap | 32.28M |
| Price to Earnings Ratio | N/A |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 108.06M |
| Average Volume (1 week) | 2.96k |
| Average Volume (1 Month) | 104.5k |
| 52 Week Change | 6.68% |
| 52 Week High | 0.388 |
| 52 Week Low | 0.241 |
| Spread (Intraday) | 0.02 (6.67%) |
| Company Name | LianBio (PK) |
| Address |
2nd floor, harbour place george town KY1 1106 |
| Website | https://www.lianbio.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
